Organon & Co. (OGN) is a Healthcare company in the Drug Manufacturers General industry. It has a market capitalization of $3.57B, a trailing price-to-earnings ratio of 4.2 and a free-cash-flow yield of 10.8%. Over the most recent reported fiscal year, revenue declined 2.9% and free cash flow per share fell 35.1%.